IP Library Granted Patent US 9,133,176
Granted Patent B2
US 9,133,176 · App. 12/119,212 · Granted Sep 15, 2015

Isolation, purification and synthesis of procyanidin B2 and uses thereof

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,133,176
App. No.
12/119,212
Granted
Sep 15, 2015
Kind
B2
Abstract

Methods for the synthesis, isolation, and purification of procyanidin B2 are disclosed. The synthetic methods utilize epicatechin as a starting material and produce procyanidin B2 in high yields. The isolation methods extract procyanidin B2 from a sample of bark powder from plant matter of the genus Uncaria . The isolated and/or synthesized procyanidin B2 is used to treat amyloid disease, such as Alzheimer's disease and Parkinson's disease as well as improve cognitive performance and increase learning and memory in Alzheimer's patients. Pharmaceutical compositions containing the synthesized and/or isolated procyanidin B2 are also disclosed.

Claims (9)

1. A method for improving cognitive performance and/or slowing cognitive decline in a patient suffering from an amyloid disease comprising administering a therapeutically effective amount of a procyanidin B2 to reduce formation, deposition, accumulation, or persistence of beta-amyloid protein fibrils in the patient wherein the amount of the procyanidin B2 administered is between about 0.1 mg/kg of body weight and about 1000 mg/kg of body weight of the patient per day.

2. The method of claim 1 , wherein the amount of the procyanidin B2 administered is between about 1 mg/kg of body weight per day and about 100 mg/kg of body weight per day.

3. The method of claim 1 , wherein the amount of the procyanidin B2 administered is between about 10 mg/kg of body weight per day and about 100 mg/kg of body weight per day.

4. A method for improving learning and/or memory in an Alzheimer's patient comprising administering a therapeutically effective amount of a procyanidin B2 to reduce formation, deposition, accumulation, or persistence of beta-amyloid protein fibrils in the patient, wherein the amount of the procyanidin B2 administered is between about 0.1 mg/kg of body weight and about 1000 mg/kg of body weight of the patient per day.

5. The method of claim 4 , wherein the amount of the procyanidin B2 administered is between about 1 mg/kg of body weight per day and about 100 mg/kg of body weight per day.

6. The method of claim 5 , wherein the amount of the procyanidin B2 administered is between about 10 mg/kg of body weight per day and about 100 mg/kg of body weight per day.

7. A method for improving cognitive performance and/or slowing cognitive decline in a patient suffering from an amyloid disease comprising administering a therapeutically effective amount of a procyanidin B2 wherein the amount of the procyanidin B2 administered is between about 0.1 mg/kg of body weight and about 1000 mg/kg of body weight of the patient per day.

8. The method of claim 7 , wherein the amount of the procyanidin B2 administered is between about 1 mg/kg of body weight per day and about 100 mg/kg of body weight per day.

9. The method of claim 7 , wherein the amount of the procyanidin B2 administered is between about 10 mg/kg of body weight per day and about 100 mg/kg of body weight per day.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 8, 2016
From: PROTAMED, INC.
To: COGNITIVE CLARITY INC.
Reel/Frame 037926/0163 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 9, 2010
From: CASTILLO, GERARDO; NGUYEN, BETH; CHOI, PAULA; LARSEN, LESLEY; LORIMER, STEPHEN; SNOW, ALAN
To: PROTEOTECH INC.
Reel/Frame 025488/0286 →